Serine 331 and Tyrosine 333 Are Both Involved in the Interaction between the Cytosolic Domain of TGN38 and the µ2 Subunit of the AP2 Clathrin Adaptor Complex*

(Received for publication, November 27, 1996, and in revised form, March 31, 1997)

David J. Stephens Dagger , Colin M. Crump Dagger , Anthony R. Clarke and George Banting §

From the Department of Biochemistry, University of Bristol, University Walk, Bristol BS8 1TD, United Kingdom

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

TGN38 is a type I integral membrane protein that cycles between the trans-Golgi network and the plasma membrane. Internalization at the cell surface and targeting back to the trans-Golgi network is dependent on a hexapeptide motif, SDYQRL, in the cytosolic tail of the protein. It was recently demonstrated that this motif specifically interacts with the µ2 subunit of the AP2 adaptor complex. We have studied the interaction between the entire cytosolic domain of TGN38 and µ2 using the yeast two hybrid system, in vitro binding of recombinant fusion proteins and IAsys optical biosensor technology. A specific interaction has been demonstrated in each of the systems we have employed. We have shown an absolute requirement for Tyr-333 of TGN38 in binding to µ2. In addition we found that mutation of Ser-331 to alanine reduces the affinity of the interaction. By measuring tryptophan fluorescence at equilibrium, we have also determined the dissociation constant for the interaction between the entire cytosolic tail of TGN38 and µ2 as 58 nM. In contrast to previously published work, our data suggest that not only Tyr-333 but also its context is important in determining the specificity of binding of TGN38 to µ2.


INTRODUCTION

Efficient cell surface internalization of many proteins is mediated by their sequestration into endocytic vesicles. The hallmark feature of the process is the localization of endocytic proteins to clathrin-coated pits at the plasma membrane and their subsequent internalization in coated vesicles. Formation of the coated vesicle depends on recruitment of the vesicle coat to the plasma membrane. The coat of clathrin-coated vesicles involves binding of adaptor complexes onto the membrane and their subsequent binding of soluble clathrin. The adaptor complexes are also believed to be involved in the selective concentration of cargo proteins into coated pits.

The high efficiency internalization of many different proteins at the cell surface has been shown to be mediated through targeting signals within the cytosolic domain. Many proteins including the transferrin receptor, mannose-6-phosphate receptor, and TGN38 have tyrosine-based internalization motifs conforming to the consensus, YXXempty , where empty  represents a hydrophobic amino acid within their cytosolic domains (1). TGN38 is a type I transmembrane glycoprotein that cycles between the trans-Golgi network (TGN)1 and the plasma membrane (2-6). The tyrosine-based motif of TGN38 is located within the hexapeptide SDYQRL. This sequence has been shown to be responsible for the high efficiency internalization of the protein at the cell surface and its subsequent targeting back to the trans-Golgi network (3-5). Various roles have been proposed for TGN38 (7), but its precise function remains to be elucidated.

The best characterized of the adaptor complexes are AP1 and AP2, which bind to TGN membranes and the plasma membrane, respectively (8, 9). Both are composed of two large (>100 kDa) adaptin subunits (beta ' and gamma  for AP1 and beta  and alpha  for AP2), a medium chain (µ) subunit, and a small (sigma ) chain subunit. The beta  subunits of both AP1 and AP2 complexes have been shown to bind to clathrin (10, 11). Several proteins are known to bind directly to the AP2 adaptor complex. For example, epidermal growth factor receptors can be co-immunoprecipitated with AP2 complexes in stoichiometric amounts (12, 13). Purified adaptor complexes have also been shown to bind synthetic peptides corresponding to regions within the cytosolic domains of the mannose-6-phosphate receptor, low density lipoprotein receptor, and lysosomal acid phosphatase, all of which have tyrosine-based sorting signals in their cytosolic domains (14-16). It was recently shown that the tyrosine-based internalization signal of TGN38, SDYQRL (Fig. 1), interacts with the medium chain subunit (µ2) of the plasma membrane adaptor complex, AP2 (17) which suggests a role for the µ subunits in mediating interaction with, at least some, tyrosine-based targeting signals. The tyrosine motif of Lamp-1 (lysosomal associated membrane protein-1, GYQTI) has also recently been shown to bind to both AP1 and AP2 in vitro (18).


Fig. 1. Amino acid sequence of the cytosolic domain of TGN38. The sequence of the cytosolic domain of TGN38 is shown. The internalization motif is underlined. Mutations used in this study are shown.
[View Larger Version of this Image (6K GIF file)]

The interaction between TGN38 and the µ2 subunit was initially detected by screening a yeast two hybrid library with a triplet repeat of the hexapeptide motif SDYQRL (17). The system was also used to show that the triplet repeat (SDYQRL)3 could interact with the µ1 subunit of AP1, the TGN adaptor complex. A single copy of the repeat sequence as well as the complete cytosolic domain of TGN38 were also shown to interact with µ2. The specificity of interaction was confirmed from binding assays using in vitro translated µ2 and a GST-(SDYQRL)3 fusion protein. The data obtained from these experiments showed an absolute requirement for the tyrosine residue of the motif, in agreement with previously published data (3-5). Binding could also be competed using a synthetic peptide corresponding to the same sequence.

We decided to examine the interaction between the complete cytosolic tail of TGN38 and µ2 in more detail. Apart from demonstrating an interaction between the two proteins in the two hybrid system, Ohno et al. (17) presented no further work using the entire TGN38 tail sequence. As well as confirming the importance of Tyr-333 of TGN38, we have examined the effect of mutating Ser-331 of the SDYQRL motif to alanine with regard to µ2 binding. This residue has previously been shown to be important for both internalization of TGN38 at the cell surface and targeting back to the TGN (5). We have used the two hybrid system, interaction of recombinant fusion proteins, and optical biosensor technology to study the interaction. In addition, the equilibrium dissociation constant for the interaction has been determined by fluorescence quenching. Our data support previous observations (17) with the exception that we show a clear role for the serine residue of the SDYQRL motif in determining the specificity of binding. This suggests that the context of the sequence and not only the presence of the tyrosine motif is important in determining molecular recognition by the adaptor complexes.


EXPERIMENTAL PROCEDURES

All reagents were purchased from Sigma (Poole, UK) unless otherwise stated. All plasmid manipulations were carried out according to standard methodologies (19).

Mutagenesis of TGN38

Mutations were introduced into TGN38 by PCR using primers incorporating the mutated codons. Mutation S331A was initially incorporated into the full TGN38 coding sequence, which was then used as a PCR template to amplify the cytosolic domain. The mutation Y333A was incorporated into a construct lacking the four carboxyl-terminal residues of TGN38 that were added back during subsequent amplification of the cytosolic domain alone. Primer sequences were as follows: S331A, 5'-AAGCTTTAGGTTCAAACGTTGGTAGTCAGCGGCCTTTGG-3'; Y333A, 5'-CAAACGTTGGGCGTCAGCGGCCTTTGG-3'. Each primer was used in conjunction with a sense TGN38 primer incorporating an Asp718I site at the extreme 5' end of the TGN38 coding region: 5'-GGTACCAGACTACAGGATGCAGTTCCTGG-3'. All oligonucleotides were synthesized within the Biotechnology and Biological Sciences Research Council funded Molecular Recognition Center of the University of Bristol.

Plasmid Manipulation

All sequences were amplified for subcloning by 10 cycles of PCR using 2 units of Taq DNA polymerase (Boehringer Mannheim, Lewes, UK), 0.2 mM dNTPs, 1.5 mM MgCl2, and 5 pmol of each primer. PCR products were gel purified and subcloned via pGEM-T (Promega, Southampton, UK) to the target vector using standard methods (19). All sequences amplified by PCR were confirmed by automated DNA sequencing.

µ1 and µ2

cDNAs encoding rat µ1 and µ2 were kindly provided by Dr. M. S. Robinson (University of Cambridge, UK). The full coding sequence of each was amplified by PCR and subcloned, in frame, into (i) the two hybrid activation domain vector, pVP16 (20), creating pVP16-µ1 and pVP16-µ2, respectively, and (ii) the plasmid-based prokaryotic expression vector pET32a (Novagen, Abingdon, UK) for bacterial expression. Amino-terminally truncated µ2 (corresponding to amino acids 121-435 of µ2, generating µ2Delta N) was also made and subcloned into pET32a.

TGN38

Wild-type and mutant versions of the cytosolic tail of TGN38 were amplified by PCR and subcloned into (i) pGEX4T (Pharmacia Biotech Inc., St. Albans, UK) for expression as GST fusion proteins, (ii) pET32a (Novagen), for expression as thioredoxin fusion proteins, and (iii) the two hybrid DNA binding domain vector, pBTM116 (20).

Two Hybrid Analysis

Saccharomyces cerevisiae strain L40 (MATa his3D200 trp1-901 leu2-3, 112 ade2 LYS2::(lexAop)4-HIS3 URA3::(lexAop)8-lacZ gal4 gal80 (20)) was co-transformed with plasmids to express TGN38 cytosolic tail variants as LexA fusions and µ1 or µ2 as VP16 fusions, according to previously published methods (21). Cells were also transformed with pVP16-µ1/µ2 and pLexA-Lamin as a negative control for interaction. Cells were then washed in TE (10 mM Tris-HCl, pH 7.5, 1 mM EDTA) and plated onto selective medium (lacking Trp and Leu). After 3-4 days, colonies were streaked onto selective medium lacking Trp, Leu, Lys, and Ura and grown at 30 °C for a further 3 days. Colonies were then assayed for beta -galactosidase activity. Colonies were lifted onto a Whatman 1 filter and frozen by submerging in liquid nitrogen for 10 s. The filter was then thawed at room temperature and layered over another filter, presoaked in Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, pH 7.0) containing 0.4 mg·ml-1 X-gal. Filters were then incubated overnight at 30 °C in humidified Petri dishes.

Expression of Recombinant Proteins

TGN38 cytosolic domains were expressed as GST fusion proteins in Escherichia coli strain BL21DE3 and purified on glutathione-agarose according to recommended protocols (Pharmacia). Briefly, cultures were inoculated with 1% (v/v) of saturated overnight culture, grown to A600 = 0.4 and induced for 1 h with 0.1 mM isopropyl-beta -D-thiogalactoside. Following sonication in 50 mM sodium phosphate, pH 7.4, supplemented with protease inhibitors (1 µg·ml-1 leupeptin, 2 µg·ml-1 antipain, 10 µg·ml-1 benzamidine, 10 units·ml-1 aprotinin, 1 µg·ml-1 chymostatin, 1 µg·ml-1 pepstatin A), purification was achieved using glutathione-agarose with washes in phosphate-buffered saline. Thioredoxin fusions were expressed in an identical manner and purified using TalonTM purification resin (CLONTECH) according to the manufacturer's instructions. All proteins were dialyzed into 50 mM sodium phosphate, pH 7.4, and stored at -70 °C.

Full-length µ2 and µ2Delta N were also expressed in BL21DE3 as follows. Cultures were inoculated with 10% (v/v) overnight culture, grown for a further 2 h at 37 °C with shaking, and induced for 30 min with 1 mM isopropyl-beta -D-thiogalactoside. Cells were pelleted and lysed by sonication; the insoluble pellet was washed twice in 100 mM sodium phosphate containing 1% (w/v) Triton X-100 before solubilization in 50 mM sodium phosphate containing 8 M urea and 10 mM dithiothreitol for 1 h at room temperature. Proteins were refolded by stepwise dialysis into lower concentrations of urea at 4 °C. Buffers for dialysis down to 0.5 M urea contained 2 mM dithiothreitol; for lower urea concentrations (less than 0.5 M), dithiothreitol was omitted and 10% glycerol was included. Finally, µ2Delta N and µ2 proteins were dialyzed into 50 mM sodium phosphate containing 10% glycerol and stored at -70 °C.

In Vitro Binding of Fusion Proteins

GST-TGN38 tail fusions (30 µg each) and Trx-µ2Delta N (10 µg) were incubated together for 1 h at room temperature in a total volume of 0.2 ml of 50 mM sodium phosphate, pH 7.4, containing 10% glycerol and supplemented with protease inhibitors (5 µg·ml-1 leupeptin, 10 µg·ml-1 antipain, 50 µg·ml-1 benzamidine, 50 units·ml-1 aprotinin, 5 µg·ml-1 chymostatin, 5 µg·ml-1 pepstatin A). Complexes were then immunoprecipitated for 1 h with a polyclonal antibody that specifically recognizes thioredoxin that had been preadsorbed to protein G-Sepharose (20 µl bed volume). Complexes were washed twice in binding buffer and separated by SDS-polyacrylamide gel electrophoresis on 12% gels and stained with Coomassie Blue R-250. Band intensities were quantitated following scanning of individual gels on a Apple Macintosh® computer using the public domain NIH Image program (developed at the U. S. National Institutes of Health and available on the Internet).2

IAsys Optical Biosensor Measurements

Experiments were performed using an IAsys resonant mirror optical biosensor (Affinity Sensors, Cambridge, UK). Thioredoxin fusions of TGN38 cytosolic domains were immobilized on carboxymethyl-dextran cuvette surfaces according to the manufacturer's instructions. Binding experiments were performed in 50 mM sodium phosphate, pH 7.4, containing 10% glycerol. µ2Delta N was added to a final concentration of 0.2 µM in a total volume of 200 µl, and changes in resonant angle were monitored at 1-s intervals for approximately 300 s. Experiments were performed at 25 °C with a stirrer speed of 100 rpm. For repeated measurements using the same cuvette, surfaces were regenerated by washing for 2 min in 200 mM formic acid. For peptide competition experiments, µ2Delta N was preincubated with 10 µM peptide (CKASDYQRLNLKL) for 1 h at room temperature before addition to the cuvette.

Fluorimetry

Fluorescence emission was monitored between 300 and 450 nm following excitation at 290 nm using a Perkin-Elmer fluorimeter. A 2-ml cuvette containing Trx-µ2Delta N at 50 nM was used. 5-µl aliquots of GST-TGN38 fusion were added sequentially (each addition increasing the concentration of GST fusion in the cuvette by 30 nM), and fluorescence emission was monitored. A base line of fluorescence from the buffer alone was subtracted from each data set prior to analysis. Data were plotted and analyzed using the GraFit package. Data were analyzed according to the following equations describing the addition of B (GST-TGN38 fusion) to A (Trx-µ2Delta N), and the equilibrium dissociation constant (Kd) was calculated: Fluorescence, F = Ia·[A] + Ib·[B] + Iab·[AB], where I represents the fluorescence intensity, [A] represents the concentration of unbound A, [B] represents the concentration of unbound B, and [AB] represents the concentration of AB complex; [A] = [A]o·(1 - alpha ), [A:B] = [A]o·alpha , [B]o - [A:B], and alpha  = (([B]o + [A]o + Kd) - ([B]o + [A]o + Kd)2 - 4[A]o·[B]o)0.5)/2.[A]o, where alpha  represents the saturation of A with B, [A]o represents the total concentration of A, [B]o represents the total concentration of B, and Kd represents the equilibrium dissociation constant.


RESULTS

Two Hybrid Analysis

Two hybrid screening (22) of a mouse spleen cDNA library with a triplet sequence of the SDYQRL motif found within the cytosolic domain of TGN38 has recently led to the identification of the µ2 subunit of the AP2 adaptor complex as a binding partner (17). Further analyses confirmed the interaction using a single copy of the motif as well as the cytosolic domain of TGN38. We have used an alternative two hybrid system to test this interaction as well as to assess the strength of interaction with µ1 and µ2 of a number of TGN38 constructs mutated in the serine or tyrosine residues of the SDYQRL motif.

In frame fusions of TGN38 cytosolic domain sequences with LexA and coding sequences of µ1 or µ2 with VP16 were generated and transformed into yeast strain L40. Fig. 2 shows the result of a two hybrid beta -galactosidase assay to test for interaction between the cytosolic domain of TGN38 and µ1 or µ2. No activation of transcription was detected with any of the constructs individually nor following co-transformation of yeast with pVP16-µ1 or pVP16-µ2 and with a negative control plasmid encoding a LexA-Lamin fusion. A positive signal was seen following cotransformation of yeast with µ2 and the wild-type cytosolic tail of TGN38 after a 6-h incubation. No interaction was observed between any of the other paired constructs even following incubation in the presence of X-gal for up to 24 h. Mutation of Tyr-333 of TGN38 to Ala (Y333A) abolished the interaction, confirming the requirement for a tyrosine-based signal. Mutation of Ser-331 to Ala (S331A) also abolished the interaction. This indicates a requirement for Ser-331 in mediating a high affinity binding of TGN38 to µ2. No interaction was detected between any of the TGN38 constructs and µ1 (the medium chain of the TGN adaptor complex, AP1).


Fig. 2. Two hybrid analysis of the interaction between the cytosolic domain of TGN38 and adaptor proteins, µ1 and µ2. Interaction between TGN38 cytosolic domain constructs and µ1 or µ2. Yeast were grown for 3 days before lifting to filter as described. beta -Galactosidase expression was assayed by overnight incubation in the presence of X-gal. Positive interactions are identified by hydrolysis of the substrate to produce a blue color. The left-hand column shows yeast transformed with pVP16-µ1; on the right are those transformed with pVP16-µ2. Cells were cotransformed with LexA fusion plasmids encoding either wild-type (WT) TGN38, Y333A mutant, S331A, or a negative control, lamin.
[View Larger Version of this Image (50K GIF file)]

Interaction of Fusion Proteins

To extend the data from the two hybrid system, we have used an in vitro system involving interaction of recombinant fusion proteins of the two binding partners. The cytosolic domain of TGN38 (and mutants thereof) was expressed as a GST fusion, and µ2 and µ2Delta N were expressed as thioredoxin fusions. Proteins were incubated together in solution followed by immunoprecipitation using a thioredoxin-specific polyclonal antibody. The strength of interaction was then assessed by Coomassie Blue staining of polyacrylamide gels. The data of Ohno et al. (17) suggested that µ2 truncated in the first 120 amino acids bound with equal efficiency to TGN38. We too observed equivalent binding of full-length and truncated µ2 to the cytosolic tail of TGN38. No in vitro data could be obtained for binding of µ1 because soluble protein could not be generated in sufficient amounts. The results of these experiments showed, in agreement with the two hybrid data, that the wild-type cytosolic domain of TGN38 interacts with µ2Delta N (Fig. 3A, lane 2). Binding was considerably reduced by mutation of either the tyrosine or serine residues of the SDYQRL motif to alanine (Fig. 3A, lanes 3 and 4, respectively). Quantitation of band intensities using the NIH Image package (Fig. 3B) showed that there was more than 2-fold greater binding of µ2Delta N to the wild-type TGN38 fusion protein compared with either S331A or Y333A mutants. A possible explanation for the observed binding of both the S331A and Y333A mutants above that of GST alone is that the GST fusion proteins used in this part of the study may have the potential to dimerize (23). Multimeric forms of the cytosolic domain of TGN38 may mediate a different interaction with µ2 than the LexA and thioredoxin fusions used for the other analyses described here. These results, however, do support the observation from the two hybrid analysis that the S331A mutation disrupts the interaction with µ2Delta N.


Fig. 3. In vitro interaction to the cytosolic domain of TGN38 and µ2. GST-TGN38 fusion proteins and Trx-µ2Delta N were incubated together for 1 h followed by immunoprecipitation with anti-Trx. Complexes were then boiled in sample buffer and separated by SDS-polyacrylamide gel electrophoresis. A, representative polyacrylamide gel. Lane 1, molecular mass markers; lane 2, wild-type TGN38; lane 3, Y333A mutant; lane 4, S331A mutant; lane 5, GST. Data from three identical experiments were analyzed using the NIH Image package and averaged. B, quantitation of binding of wild-type (WT) TGN38 (SDYQRL), Y333A (SDAQRL), and S331A (ADYQRL) to Trx-µ2Delta N. Binding of each TGN38 fusion protein is expressed relative to that of GST alone.
[View Larger Version of this Image (31K GIF file)]

IAsys Optical Biosensor Measurements

The IAsys resonant mirror optical biosensor was used to analyze the interaction between the two proteins in real time. TGN38-thioredoxin fusion proteins were immobilized onto carboxy-methyl dextran cuvettes and binding of µ2Delta N determined. The thioredoxin fusion of TGN38 was used for this part of the study due to the increased stability of these constructs over GST fusions. All TGN38 constructs as well as the thioredoxin domain alone were immobilized at a concentration of 8 ng·mm2 protein. Change in resonant angle was monitored continuously over a 5-min period following the addition of µ2Delta N to a final concentration of 200 nM in 50 mM sodium phosphate, pH 7.4, containing 10% glycerol. Binding curves for these experiments are shown in Fig. 4A. The data are consistent with those obtained from the two previous approaches. As anticipated, µ2Delta N did not bind to Trx-TGN38 fusions in which the tyrosine residue within the SDYQRL motif had been mutated to alanine. A significant reduction in binding was observed for the of Ser-331 to alanine mutant (S331A, Fig. 4A, open squares). No significant binding to thioredoxin alone was observed. Binding curves were replicated in each case following regeneration of the cuvette surface with 200 mM formic acid. Fig. 4B shows that this treatment did not reduce the bioactivity of the surface with regard to µ2Delta N binding (wt 1 and wt 2 in Fig. 4B).


Fig. 4. Measurement of interaction using the IAsys optical biosensor. Changes in resonant angle were monitored continuously using an IAsys optical biosensor over a 5 min period following the addition of Trx-µ2Delta N fusion protein (final concentration, 200 nM) to Trx-TGN38 fusions immobilized on carboxy-methyl dextran cuvette surfaces. A, binding of µ2Delta N to immobilized TGN38 fusion proteins. Binding curves are shown for wild-type TGN38, Y333A, S331A, and thioredoxin alone. B, competition of binding with synthetic peptide. Experimental conditions identical to those in A were used to obtain binding curves for wild-type TGN38 (wt 1). The surface was regenerated with 200 mM formic acid and the binding determination repeated (wt 2). Binding was then measured for µ2Delta N that had been preincubated for 1 h with 10 µM competing peptide of sequence CKASDYQRLNLKL (wt + pep). Following regeneration as before, binding of noncompeted µ2Delta N was repeated (wt 3).
[View Larger Version of this Image (22K GIF file)]

Binding of µ2Delta N was competed by preincubation with a 50-fold molar excess of synthetic peptide corresponding to part of the cytosolic tail of TGN38 overlapping the SDYQRL motif. Preincubation of µ2Delta N with the peptide followed by subsequent addition to the biosensor cuvette reduced binding significantly (Fig. 4B, wt + pep). Binding of µ2Delta N was repeated following regeneration of the surface as before to remove the peptide and any bound µ2Delta N. In this case a reduction in binding was observed (wt 3 in Fig. 4B). The level of binding was still above that seen in the presence of competing peptide but less than that seen initially. The most plausible explanation for this is that the peptide was not completely removed from the dextran matrix by formic acid treatment. The data obtained from the optical biosensor are in complete agreement with that obtained from the other approaches but also show that the effect of the S331A mutation is not as significant as that of Y333A.

Equilibrium Fluorescence

Equilibrium measurement of tryptophan fluorescence was used to determine the dissociation constant for the interaction between TGN38 and µ2Delta N. Sequential addition of GST-TGN38 to Trx-µ2Delta N would lead to linear increase in fluorescence due to the four tryptophan residues of GST-TGN38. Deviation from the linearity of this increase indicates an interaction between the two proteins. Change in fluorescence was plotted against concentration of GST-TGN38 and then subtracted from the linear increase due to sequential addition of TGN38. The resulting fluorescence quench data were curve fitted to the equation shown under "Experimental Procedures" from which the equilibrium dissociation constant (Kd) was calculated (Fig. 5). Using this method the Kd for the interaction between wild-type TGN38 tail and µ2Delta N was calculated as 58 nM (standard error ± 7). The Kd for the interaction of the S331A fusion with µ2Delta N was similarly determined as 103 nM (standard error ± 8). The dissociation constant for the binding of the Y333A mutant was found to be 755 nM (standard error ± 100). These data are in entirely consistent with those obtained from the other approaches described here. In particular, the lower affinity of the S331A mutant compared with the wild-type protein for µ2Delta N reflects the binding curve obtained using the IAsys optical biosensor, suggesting that the mutation S331A does indeed affect the binding of the cytosolic domain of TGN38 to µ2Delta N.


Fig. 5. Equilibrium fluorescence analysis of binding. A, change in fluorescence on addition of GST-TGN38 fusions to Trx-µ2Delta N. The solid line indicates the background change in fluorescence that is due tryptophan residues within the GST domain of the fusion proteins. open circle , wild type; square , S331A; bullet , Y333A. B, binding curves were determined from the data in A and curve fitted according to the equations under "Experimental Procedures," and equilibrium dissociation constants were calculated.
[View Larger Version of this Image (20K GIF file)]


DISCUSSION

We have used a number of complementary approaches to study the interaction of a tyrosine-based internalization signal with the medium chain component, µ2, of the adaptor complex, AP2. We have studied the internalization signal of TGN38, SDYQRL, which in isolation has previously been shown to interact with the µ2 protein in a two hybrid system and in an in vitro binding assay (17). The context of critical tyrosine residues within internalization signals is almost certainly important for specificity, for example, the spacing of the tyrosine motif of lamp-1 from the membrane is critical for interaction with the TGN adaptor complex, AP1 (24). The triplet repeats used by Ohno et al. (17) would obviously also be very different in structure to the entire cytosolic domain of TGN38, which has been shown by NMR to form a nascent helix in solution (25). For this reason, we chose to study the interaction in more detail using the entire cytosolic domain of TGN38.

Initial experiments exploited the yeast two hybrid system (22) to study the interaction. Interaction was detected between µ2 and the wild-type TGN38 cytosolic domain but not following mutation of the tyrosine or serine residues of the SDYQRL motif to alanine. No interaction was detected between the cytosolic tail of TGN38 and µ1. This is in conflict with the results of Ohno et al. (17), who readily detected an interaction between a triplet repeat of SDYQRL and µ1. This suggests that the interaction, if any, between the entire cytosolic tail of TGN38 and µ1 is too weak to be detected using the sensitive two hybrid system we employed. It can be inferred from this that the context of the critical tyrosine residue is an important determinant of adaptor binding. Indeed, recent surface plasmon resonance data from the same group showed that the cytosolic domain of TGN38 does bind to AP1 with lower affinity than AP2 (26) in agreement with our two hybrid data. Similarly, the endocytic signal of the epidermal growth factor receptor has been shown to bind to AP1 with lower affinity than to AP2 (27).

The two hybrid experiments reported here also show an importance for Ser-331 of the SDYQRL motif in determining binding specificity. This result complements the earlier biological observation that mutation of serine-331 plays a role in determining the intracellular localization of TGN38 (5). Ohno et al. demonstrated that mutation of this residue to alanine did not affect binding of an isolated SDYQRL motif to µ2 when assayed for growth on histidine-deficient medium (17). These growth assays are not quantitative, and so it is difficult to determine the relative importance of this mutation. In our hands the same mutation, in the context of the entire cytosolic tail sequence, completely abolished interaction with µ2 as evidenced by lack of activation of transcription of the beta -galactosidase reporter gene. More recently, two hybrid screening of a combinatorial cDNA library of constructs ending AAYXXX (26) also failed to show any role for Ser-331 of TGN38 in mediating binding to µ2. Again, this discrepancy with our data is most easily explained by the context of the tyrosine motif. Our constructs have the additional four amino acids (NLKL) of TGN38 present, whereas those used for screening of the combinatorial library did not. Thus, although the tetrapeptide sequence of YXXempty may be sufficient for directing binding to µ2, it is clear that the exact sequence context of these motifs affects the affinity of binding and therefore presumably the efficiency of sorting into endocytic vesicles.

To complement the two hybrid data, we investigated the interaction between recombinant fusion proteins of the two binding partners. Fusion proteins were incubated together, and complexes were immunoprecipitated and analyzed by SDS-polyacrylamide gel electrophoresis. Using this approach we were able to detect binding of the wild-type cytosolic domain of TGN38 to µ2Delta N (a µ2 construct deleted in the first 120 amino acids, a modification that has been shown not to alter binding to the cytosolic domain of TGN38; Ref. 17). In addition, this result confirmed the observation apparent from our two hybrid results that both Ser-331 and Tyr-333 of the cytosolic domain of TGN38 are important in mediating a high affinity interaction with µ2Delta N.

In addition to the above approaches, we have utilized the IAsys resonant mirror optical biosensor to investigate the interaction between TGN38 and µ2Delta N. The biosensor measures changes in resonant angle that occur on binding of, in this case, µ2Delta N to TGN38 cytosolic domains immobilized on a cuvette surface in real time. No binding of the thioredoxin fusion domain alone was observed, indicating that any interaction observed is due to the µ2Delta N domain. We were able to confirm the absolute requirement of Tyr-333 in the interaction because mutation to alanine (Y333A) abolished the interaction. In addition, binding was also competable using a synthetic peptide containing the SDYQRL motif. The inhibition of binding was significant but not complete, probably due to insufficiently high peptide concentrations (10 µM). Indeed Heilker et al. (28) found that 20 µM peptide did not significantly affect binding of internalization motifs to adaptor complexes as assessed by surface plasmon resonance. Very high concentrations of competing peptide were also required for competition of binding of lamp-1 to adaptor complexes (18). This may be a feature of the different affinities of the free peptide and immobilized fusion protein for µ2 resulting from the context or presentation of the tyrosine motif. The peptide used in this study had only four residues upstream of the SDYQRL motif, and it is possible that this greatly reduced the affinity of interaction with µ2 compared with the entire cytosolic domain of TGN38. The fact that binding was at least to some extent competable suggests specificity of interaction.

Due to the exquisite sensitivity of the system, the IAsys experiments showed an effect of Ser-331 in determining efficiency of binding not apparent from the two hybrid analyses or immunoprecipitation. Mutation of this residue to alanine (S331A) significantly reduced the amount of binding detected as well as the initial rate of the interaction but unlike the Y333A mutation caused only a partial disruption of binding. This suggests that in the context of the complete TGN38 tail sequence, this upstream residue is important in determining the affinity of interaction between TGN38 and the adaptor complex and is consistent with previously published data implicating Ser-331 in internalization and return of TGN38 to the TGN (5). Furthermore, overexpression of S331A TGN38 in COS-7 cells does lead to enhanced expression of TGN38 at the cell surface compared with similar levels of expression of wild-type TGN38.3

To determine the equilibrium dissociation constant for the interaction between TGN38 and µ2, we studied quenching of tryptophan fluorescence on binding. On addition of TGN38 fusion proteins, a nonlinear increase of fluorescence was observed, and from this dissociation constants for the interactions were calculated. Strong binding of the wild-type cytosolic domain of TGN38 to µ2Delta N was observed (Kd = 58 nM) with somewhat weaker binding for the S331A mutant (Kd = 103 nM). Binding of the Y333A mutant was significantly lower (Kd>700 nM). Interaction was barely detectable with this mutant as evidenced by the low confidence limits of the calculated dissociation constant (standard error = ±100 nM). This quantitative approach confirms the observations from the other techniques described here. The data confirm that the tyrosine residue within the SDYQRL motif of TGN38 is essential for binding to the µ2 chain of the AP2 complex and in addition indicate that the serine residue within this motif is also important in mediating high affinity binding to the complex.

Our data are somewhat in conflict with previously published results (17) because they indicate an important role for residues other than the tyrosine and bulky hydrophobic residue of the YXXempty consensus in determining specificity of binding of tyrosine-based targeting motifs to adaptors. This additional specificity may have a role in determining the subcellular compartment to which proteins are ultimately targeted. This may be of particular relevance to TGN38 given the demonstration of a role for Ser-331 in return of the protein from the cell surface to the TGN (5). The greater affinity of interaction shown here between TGN38 and µ2 compared with µ1 might account for the observed traffic of TGN38 to the cell surface and its subsequent internalization as opposed to µ1-mediated transport direct from the TGN to lysosomal compartments. Similar differences in binding affinity of TGN38 to adaptor complexes at the level of the sorting endosome could mediate transport to the TGN as opposed to entering a recycling pathway such as that seen for the transferrin receptor.

In summary, we have shown using three complementary approaches that the complete cytosolic tail of TGN38 interacts with the µ2 subunit of the AP2 adaptor complex. The interaction has been shown to occur in free solution, intracellularly (using the two hybrid system) and also by recruitment of µ2Delta N to immobilized TCN38 tails (IAsys measurements). The equilibrium dissociation constant (Kd) for the interaction is 58 nM. The interaction has been shown to be dependant not only on the tyrosine residue of the internalization motif of TGN38 but also on the serine residue upstream of this YXXempty motif.


FOOTNOTES

*   This work was supported by the Medical Research Council and Biotechnology and Biological Sciences Research Council.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    These authors contributed equally to this work.
§   To whom correspondence should be addressed. Tel.: 44-117-928-8272; Fax: 44-117-928-8274; E-mail: bantingg{at}bsa.bristol.ac.uk.
1   The abbreviations used are: TGN, trans-Golgi network; Trx, thioredoxin A; GST, glutathione S-transferase; PCR, polymerase chain reaction; X-gal, 5-bromo-4-chloro-3-indolyl beta -D-galactopyranoside.
2   The Internet address is http://rsb.info.nih.gov/nih-image.
3   E. P. Roquemore and G. Banting, submitted for publication.

ACKNOWLEDGEMENTS

We thank Dr. M. S. Robinson (University of Cambridge) for providing cDNAs of µ1 and µ2, Drs. S. Hollenberg, P. Bartel, and S. Fields for the two hybrid vectors and yeast strain, Dr. M. Dickens (University of Bristol) for help and advice on two hybrid system, Drs. S. Mayes and P. Buckle of Affinity Sensors for loaning and providing excellent technical assistance for the IAsys system, and Drs E. P. Roquemore and B. J. Reaves for the TGN38 mutant constructs.


REFERENCES

  1. Trowbridge, I. S., Collawn, J. F., and Hopkins, C. R. (1993) Annu. Rev. Cell Biol. 9, 129-161 [CrossRef]
  2. Luzio, J. P., Brake, B., Banting, G., Howell, K. E., Braghetta, P., and Stanley, K. K. (1990) Biochem. J. 270, 97-102 [Medline] [Order article via Infotrieve]
  3. Bos, K., Wraight, C., and Stanley, K. K. (1993) EMBO J. 12, 2219-2228 [Abstract]
  4. Humphrey, J. S., Peters, P. J., Yuan, L. C., and Bonifacino, J. S. (1993) J. Cell Biol. 120, 1123-1135 [Abstract]
  5. Wong, S. H., and Hong, W. (1993) J. Biol. Chem. 268, 22853-22862 [Abstract/Free Full Text]
  6. Reaves, B., Horn, M., and Banting, G. (1993) Mol. Biol. Cell 4, 93-105 [Abstract]
  7. Banting, G., and Ponnambalam, S. (1997) Biochem. Biophys. Acta 1355, 209-217 [Medline] [Order article via Infotrieve]
  8. Pearse, B., and Robinson, M. S. (1990) Annu. Rev. Cell Biol. 6, 151-171 [CrossRef]
  9. Robinson, M. S. (1994) Curr. Biol. 6, 538-544
  10. Ahle, S., and Ungewickell, E. (1989) J. Biol. Chem. 264, 20089-20093 [Abstract/Free Full Text]
  11. Gallusser, A., and Kirchhausen, T. (1993) EMBO J. 12, 5237-5244 [Abstract]
  12. Sorkin, A., and Carpenter, G. (1993) Science 261, 612-615 [Medline] [Order article via Infotrieve]
  13. Sorkin, A., McKinsey, T., Shih, W., Kirchhausen, T., and Carpenter, G. (1995) J. Biol. Chem. 270, 619-625 [Abstract/Free Full Text]
  14. Pearse, B. M. F. (1988) EMBO J. 7, 3331-3336 [Abstract]
  15. Glickman, J. N., Conibear, E., and Pearse, B. M. F. (1989) EMBO J. 8, 1041-1047 [Abstract]
  16. Sosa, M. A., Schmidt, B., von Figura, K., and Hille-Rehfeld, A. (1993) J. Biol. Chem. 268, 12537-12543 [Abstract/Free Full Text]
  17. Ohno, H., Stewart, J., Fournier, M.-C., Bosshart, H., Rhee, I., Miyatake, S., Saito, T., Gallusser, A., Kirchhausen, T., and Bonifacino, J. S. (1995) Science 269, 1872-1875 [Medline] [Order article via Infotrieve]
  18. Honing, S., Griffith, J., Geuze, H. J., and Hunziker, W. (1996) EMBO J. 15, 5230-5239 [Abstract]
  19. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., pp. 1.3-1.105, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  20. Vojtek, A. B., Hollenberg, S. M., and Cooper, J. A. (1993) Cell 74, 205-214 [Medline] [Order article via Infotrieve]
  21. Gietz, D., St. Jean, A., Woods, R. A., and Schiestl, R. H. (1992) Nucleic Acids Res. 20, 1425 [Medline] [Order article via Infotrieve]
  22. Fields, S., and Song, O. (1989) Nature 340, 245-246 [CrossRef][Medline] [Order article via Infotrieve]
  23. Ji, X., Zhang, P., Armstrong, R. N., and Gilliland, G. L. (1992) Biochemistry 267, 4296-4299
  24. Rohrer, J., Schweizer, A., Russell, D., and Kornfeld, S. (1996) J. Cell Biol. 132, 565-576 [Abstract]
  25. Wilde, A., Dempsey, C., and Banting, G. (1994) J . Biol. Chem. 269, 7131-7136 [Abstract/Free Full Text]
  26. Boll, W., Ohno, H., Songyang, Z., Rapoport, I., Cantley, L. C., Bonifacino, J. S., and Kirchhausen, T. (1996) EMBO J. 15, 5789-5795 [Abstract]
  27. Boll, W., Gallusser, A., and Kirchhausen, T. (1995) Curr. Biol. 5, 1168-1178 [Medline] [Order article via Infotrieve]
  28. Heilker, R., Manning-Krieg, U., Zuber, J.-F., and Spiess, M. (1996) EMBO J. 15, 2893-2899 [Abstract]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.